Cargando…
Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy
Cluster of differentiation 47 (CD47)/signal regulatory protein alpha (SIRPα) is a negative innate immune checkpoint signaling pathway that restrains immunosurveillance and immune clearance, and thus has aroused wide interest in cancer immunotherapy. Blockade of the CD47/SIRPα signaling pathway shows...
Autores principales: | Huang, Bo, Bai, Zhaoshi, Ye, Xinyue, Zhou, Chenyu, Xie, Xiaolin, Zhong, Yuejiao, Lin, Kejiang, Ma, Lingman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517548/ https://www.ncbi.nlm.nih.gov/pubmed/34712395 http://dx.doi.org/10.1016/j.csbj.2021.09.036 |
Ejemplares similares
-
Cancer Therapy Targeting CD47/SIRPα
por: Dizman, Nazli, et al.
Publicado: (2021) -
The SIRPα–CD47 immune checkpoint in NK cells
por: Deuse, Tobias, et al.
Publicado: (2021) -
CD47–SIRPα-targeted therapeutics: status and prospects
por: Maute, R., et al.
Publicado: (2022) -
Membrane-Mediated Cooperative Interactions of CD47 and SIRPα
por: Li, Long, et al.
Publicado: (2023) -
Insights into CD47/SIRPα axis-targeting tumor immunotherapy
por: Zhang, Xuyao, et al.
Publicado: (2018)